Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-25 @ 2:41 AM
NCT ID:
NCT02428933
Eligibility Criteria:
Inclusion Criteria:
* Male
* Caucasian origin
* Subjects should be able and willing to give informed consent
* 18-30 years old
* BMI range of 19-25 kg/m2
Exclusion Criteria:
* Renal failure (creatinine\>135mmol/l)
* Liver failure (AST/ (Alanine Aminotransferase) ALT \> 3 times higher than the normal upper value)
* Daily use of prescription medication
* Known hypersensitivity to bromocriptine, domperidone maleate or other ergot alkaloids.
* Uncontrolled hypertension
* Known history of coronary artery disease, or other severe cardiovascular conditions (such as a prolonged Qtc-time), or symptoms / history of severe psychiatric disorders.
* Known cardiac valvulopathy
* Prolactin-releasing pituitary tumor (prolactinoma).
* Cases where stimulation of the gastric motility could be harmful: gastro-intestinal haemorrhage, mechanical obstruction or perforation.
* Subjects with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
* Prior participation in a research protocol involving radiation exposure in the last 2 years
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
30 Years
Study:
NCT02428933
Study Brief:
Protocol Section:
NCT02428933